Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 4
2001 1
2002 1
2003 3
2005 2
2006 1
2007 1
2008 3
2010 1
2011 2
2012 4
2013 4
2014 10
2015 10
2016 10
2017 13
2018 11
2019 8
2020 10
2021 14
2022 18
2023 12
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Results by year

Filters applied: . Clear all
Page 1
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.
Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, Bedossa P, Geier A, Beckebaum S, Newsome PN, Sheridan D, Sheikh MY, Trotter J, Knapple W, Lawitz E, Abdelmalek MF, Kowdley KV, Montano-Loza AJ, Boursier J, Mathurin P, Bugianesi E, Mazzella G, Olveira A, Cortez-Pinto H, Graupera I, Orr D, Gluud LL, Dufour JF, Shapiro D, Campagna J, Zaru L, MacConell L, Shringarpure R, Harrison S, Sanyal AJ; REGENERATE Study Investigators. Younossi ZM, et al. Lancet. 2019 Dec 14;394(10215):2184-2196. doi: 10.1016/S0140-6736(19)33041-7. Epub 2019 Dec 5. Lancet. 2019. PMID: 31813633 Free article. Clinical Trial.
Global multi-stakeholder endorsement of the MAFLD definition.
Méndez-Sánchez N, Bugianesi E, Gish RG, Lammert F, Tilg H, Nguyen MH, Sarin SK, Fabrellas N, Zelber-Sagi S, Fan JG, Shiha G, Targher G, Zheng MH, Chan WK, Vinker S, Kawaguchi T, Castera L, Yilmaz Y, Korenjak M, Spearman CW, Ungan M, Palmer M, El-Shabrawi M, Gruss HJ, Dufour JF, Dhawan A, Wedemeyer H, George J, Valenti L, Fouad Y, Romero-Gomez M, Eslam M; Global multi-stakeholder consensus on the redefinition of fatty liver disease. Méndez-Sánchez N, et al. Lancet Gastroenterol Hepatol. 2022 May;7(5):388-390. doi: 10.1016/S2468-1253(22)00062-0. Epub 2022 Mar 3. Lancet Gastroenterol Hepatol. 2022. PMID: 35248211 Free article. No abstract available.
Reply.
De Vincentis A, Tavaglione F, Romeo S, Vespasiani-Gentilucci U. De Vincentis A, et al. Among authors: vespasiani gentilucci u. Clin Gastroenterol Hepatol. 2022 Nov;20(11):2660-2661. doi: 10.1016/j.cgh.2022.01.010. Epub 2022 Jan 13. Clin Gastroenterol Hepatol. 2022. PMID: 35032632 No abstract available.
Reply.
Tavaglione F, De Vincentis A, Jamialahmadi O, Vespasiani-Gentilucci U, Romeo S. Tavaglione F, et al. Among authors: vespasiani gentilucci u. Clin Gastroenterol Hepatol. 2023 Mar;21(3):856-857. doi: 10.1016/j.cgh.2022.06.008. Epub 2022 Jul 12. Clin Gastroenterol Hepatol. 2023. PMID: 35835343 No abstract available.
The authors reply.
Muley M, Finamore P, Pedone C, Margiotta DPE, Gilardi E, Sambuco F, De Vincentis A, Vespasiani-Gentilucci U, Travaglino F, Incalzi RA. Muley M, et al. Among authors: vespasiani gentilucci u. Crit Care Med. 2023 Jun 1;51(6):e138-e139. doi: 10.1097/CCM.0000000000005882. Epub 2023 May 18. Crit Care Med. 2023. PMID: 37199561 No abstract available.
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women.
Cherubini A, Ostadreza M, Jamialahmadi O, Pelusi S, Rrapaj E, Casirati E, Passignani G, Norouziesfahani M, Sinopoli E, Baselli G, Meda C, Dongiovanni P, Dondossola D, Youngson N, Tourna A, Chokshi S, Bugianesi E; EPIDEMIC Study Investigators; Della Torre S, Prati D, Romeo S, Valenti L. Cherubini A, et al. Nat Med. 2023 Oct;29(10):2643-2655. doi: 10.1038/s41591-023-02553-8. Epub 2023 Sep 25. Nat Med. 2023. PMID: 37749332 Free PMC article.
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores.
Bianco C, Jamialahmadi O, Pelusi S, Baselli G, Dongiovanni P, Zanoni I, Santoro L, Maier S, Liguori A, Meroni M, Borroni V, D'Ambrosio R, Spagnuolo R, Alisi A, Federico A, Bugianesi E, Petta S, Miele L, Vespasiani-Gentilucci U, Anstee QM, Stickel F, Hampe J, Fischer J, Berg T, Fracanzani AL, Soardo G, Reeves H, Prati D, Romeo S, Valenti L. Bianco C, et al. Among authors: vespasiani gentilucci u. J Hepatol. 2021 Apr;74(4):775-782. doi: 10.1016/j.jhep.2020.11.024. Epub 2020 Nov 25. J Hepatol. 2021. PMID: 33248170 Free PMC article.
The use of SAMe in chemotherapy-induced liver injury.
Vincenzi B, Russo A, Terenzio A, Galvano A, Santini D, Vorini F, Antonelli-Incalzi R, Vespasiani-Gentilucci U, Tonini G. Vincenzi B, et al. Among authors: vespasiani gentilucci u. Crit Rev Oncol Hematol. 2018 Oct;130:70-77. doi: 10.1016/j.critrevonc.2018.06.019. Epub 2018 Jul 31. Crit Rev Oncol Hematol. 2018. PMID: 30196914 Review.
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management.
Gallo P, Silletta M, De Vincentis A, Lo Prinzi F, Terracciani F, Di Fazio G, Flagiello V, Vespasiani Gentilucci U, Antonelli Incalzi R, Picardi A. Gallo P, et al. Among authors: vespasiani gentilucci u. Chemotherapy. 2022;67(3):152-163. doi: 10.1159/000521741. Epub 2021 Dec 31. Chemotherapy. 2022. PMID: 34974449 Free article. Review.
Exhaled breath analysis in hepatology: State-of-the-art and perspectives.
De Vincentis A, Vespasiani-Gentilucci U, Sabatini A, Antonelli-Incalzi R, Picardi A. De Vincentis A, et al. Among authors: vespasiani gentilucci u. World J Gastroenterol. 2019 Aug 14;25(30):4043-4050. doi: 10.3748/wjg.v25.i30.4043. World J Gastroenterol. 2019. PMID: 31435162 Free PMC article.
127 results